200780.KQ
BCWORLD PHARM. Co., Ltd.
KOE · Healthcare · Drug Manufacturers - General · KR
KRW 3,045.00
−0.65%Year over year
Reported trailing growth
- Revenue
- +6.7%
- EBITDA
- -39.6%
- EBIT
- -17.7%
- EPS
- +29.5%
- Free cash flow
- —
- Operating cash flow
- -28.4%
Forward estimates
Based on analyst estimates
- Revenue
- —
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +1.4%
- EBITDA
- +1.4%
- EBIT
- +2.4%
- Net income
- -10.5%
- EPS
- -10.6%
- Free cash flow
- +52.9%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026